Sole Source: Illumina Urinary Pathogen Identification (ID)/Antimicrobial Resistance (AMR) Enrichment Kits (UPIP) and Respiratory kits

The Defense Health Agency Contracting Activity (DHACA) intends to award a sole source supply contract to Illumina, Inc. for the procurement of Illumina Urinary Pathogen Identification (ID)/Antimicrobial Resistance (AMR) Enrichment Kits (UPIP) and Respiratory kits for the Department of Clinical Investigation (DCI) at Tripler Army Medical Center, Hawaii. The objective of this sole source award is to procure specific sequencing supplies for the Government-owned MiSeq Systems. Illumina, Inc. is the only vendor that can meet the Government's minimum requirements. * The contract includes the procurement of one (1) Illumina Urinary Pathogen Identification (ID)/Antimicrobial Resistance (AMR) Enrichment Kit (UPIP) * One (1) Respiratory Pathogen ID/AMR Enrichment Kit Set A * One (1) Respiratory Pathogen ID/AMR Enrichment Kit Set B * Eight (8) PhiX Control v3 * Nine (9) NextSeq 1000/2000 P1 XLEAP-SBS Reagents * Ten (10) MiSeq i100 Plus 50M Reagent Kit * The delivery date is September 1, 2026 * The delivery location is Tripler Army Medical Center, Department of Clinical Investigation, 1 Jarrett White Road, Bldg 40, Tripler AMC, HI 96859-5000